Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome
Author(s) -
Nishimoto Koshiro,
Santo Noriaki Lukas,
Yonamine Masato,
Takekoshi Kazuhiro,
Kaneko Go,
Shirotake Suguru,
Fukushima Hisayo,
Okada Yoshitaka,
Yasuda Masanori,
Sakurai Akihiro,
Oyama Masafumi,
Kanao Kento
Publication year - 2022
Publication title -
iju case reports
Language(s) - English
Resource type - Journals
ISSN - 2577-171X
DOI - 10.1002/iju5.12514
Subject(s) - pheochromocytoma , multiple endocrine neoplasia type 2 , multiple endocrine neoplasia , medicine , metastasis , pathology , pathological , hyperparathyroidism , thyroid carcinoma , thyroid , cancer , gene , biology , mutation , germline mutation , biochemistry
Patients with multiple endocrine neoplasia type 2A (MEN2A) harboring a pathological variant in the RET gene are characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, and hyperparathyroidism. Although pheochromocytoma is currently defined as a malignant tumor, MEN2A‐associated pheochromocytoma is known to have a small risk of metastasis. Case presentation The case was a 62‐year‐old Japanese male with bilateral pheochromocytoma, multiple metastases in the liver and bones, and a cardiac thrombus. Genetic testing revealed a pathological variant at codon 634 of the RET gene, thereby leading a diagnosis of MTC. We considered that the multiple metastases were due to MTC; however, a liver biopsy revealed metastasis of pheochromocytoma. Conclusion When pheochromocytoma precedes MTC, the diagnosis of MEN2A may be difficult.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom